个人简介 ——

2000年毕业于南京铁道医学院，获得硕士学位，毕业后工作于江苏省肿瘤医院。2013年毕业于南京医科大学，获得博士学位。

科研方向 ——

泌尿男生殖系肿瘤

发表文章 ——

1.Xu Ting（#），Xu, Zicheng（#），Cai, Hongzhou（#）， Yu, Bin，Zou, Qing（*），Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies. Diabetes Metab Res Rev. 2015 May;31(4):336-43. （影响因子3.263）
2.Ting Xu（#）, Qin Zou, Jing Wu et al. Heterogeneous nuclear riboncleoprotein U-like 1 and Poly(ADP-ribose) polymerase 1 are downregulated in renal cell carcinoma and connected with prognosis. Cancer Biomarkers 13 (2013):411-15.
3.Zehui Hong, Hui Li, Lili Li, Weilong Wang and Ting Xu（*）. Different expression patterns of histone H3K27 demethylases in renal carcinoma and bladder cancer. Cancer Biomarkers 18(2017): 125-131.
4.Qin Z, Li X, Zhang J, Tang J, Han P, Xu Z, Yu Y, Yang C, Wang C, Xu T（*）, Xu Z（*）, Zou Q.Chemotherapy with or without estramustine for treatment of castration-resistant prostate cancer: A systematic review and meta-analysis.Medicine (Baltimore). 2016 Sep;95(39):e4801.
5..Jianxin Xue, Zhiqiang Qin, Hongzhou Cai, Chuanjie Zhang, Xiao Li, Weizhang Xu, Jingyuan Wang, Zicheng Xu, Bin Yu, Ting Xu（*）, Qin Zou. Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis. Oncotarget 2017 Apr 4;8(14):23322-23336.
6.Yu Y, Li X, Liang C, Tang J, Qin Z, Wang C, Xu W, Hua Y, Shao P, Xu T（*）. The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: A meta-analysis. Medicine. 2016 Sep;95(37) : e4900.
7.须霆，徐维章，蔡宏宙等。前哨淋巴结结合大剂量干扰素治疗提高下肢恶性黑色素瘤疗效分析。现代医学，2015,43（6）697-699.